$FMC·8-K

FMC CORP · Jul 1, 7:07 AM ET

Compare

FMC CORP 8-K

Research Summary

AI-generated summary

Updated

FMC Corporation Agrees $403M Equity Investment from Tessenderlo

What Happened
FMC Corporation announced on June 30, 2026 that it entered into a Stock Purchase Agreement to sell 30,319,166 shares of its common stock to Tessenderlo Group NV at $13.30 per share for an aggregate purchase price of $403,244,907.80. Tessenderlo currently owns less than 1% of FMC and would own approximately 20.0% of the outstanding common stock after the transaction closes. The Closing is subject to customary conditions, including required regulatory approvals.

Key Details

  • Purchase price: $13.30 per share; total consideration: $403,244,907.80.
  • Post‑closing ownership: Tessenderlo expected to hold ~20.0% of outstanding common stock (from <1% today).
  • Board and governance: Tessenderlo will have one board nominee added at the first regular board meeting after Closing (if it holds ≥10%), the right to nominate directors for board consideration, and one board observer while holding ≥10%. Nominees must meet NYSE independence rules.
  • Transfer and voting limits: 36‑month lock‑up on transfers/hedging with customary exceptions; standstill restrictions while shares are held; voting commitments tied to certain ownership thresholds.
  • Registration rights: FMC will grant eight demand registration rights (no more frequently than once every 120 days) and will indemnify the investor for certain registration liabilities.
  • Documentation: The Stock Purchase Agreement (with forms of the Investor Agreement and Registration Rights Agreement) is filed as Exhibit 10.1; a press release was furnished as Exhibit 99.1.

Why It Matters
This is a material equity investment that would meaningfully change FMC’s shareholder base and give Tessenderlo significant governance rights (board nominee, observer, preemptive rights). Investors should note potential impacts on share count, voting dynamics, and future issuance decisions. The transaction is not final — it remains subject to regulatory approvals and customary closing conditions and includes transfer and lock‑up restrictions that affect liquidity and future resale of the investor’s shares.

Loading document...